ZA975858B - Melanoma associated peptide analogues and vaccines against melanoma - Google Patents
Melanoma associated peptide analogues and vaccines against melanomaInfo
- Publication number
- ZA975858B ZA975858B ZA975858A ZA975858A ZA975858B ZA 975858 B ZA975858 B ZA 975858B ZA 975858 A ZA975858 A ZA 975858A ZA 975858 A ZA975858 A ZA 975858A ZA 975858 B ZA975858 B ZA 975858B
- Authority
- ZA
- South Africa
- Prior art keywords
- melanoma
- peptide analogues
- associated peptide
- vaccines against
- ctl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3053—Skin, nerves, brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201945 | 1996-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA975858B true ZA975858B (en) | 1998-09-01 |
Family
ID=8224171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA975858A ZA975858B (en) | 1996-07-11 | 1997-07-01 | Melanoma associated peptide analogues and vaccines against melanoma |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0934405B1 (id) |
JP (2) | JP4386463B2 (id) |
AT (1) | ATE206759T1 (id) |
AU (1) | AU3693897A (id) |
CA (1) | CA2259944C (id) |
DE (1) | DE69707296T2 (id) |
ES (1) | ES2165619T3 (id) |
ID (1) | ID18726A (id) |
WO (1) | WO1998002538A1 (id) |
ZA (1) | ZA975858B (id) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040156861A1 (en) | 1996-07-11 | 2004-08-12 | Figdor Carl Gustav | Melanoma associated peptide analogues and vaccines against melanoma |
ZA975858B (en) * | 1996-07-11 | 1998-09-01 | Akzo Nobel Nv | Melanoma associated peptide analogues and vaccines against melanoma |
FR2763071B1 (fr) * | 1997-05-07 | 2003-05-16 | Centre Nat Rech Scient | Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic |
CA2295321C (en) * | 1997-06-23 | 2008-01-29 | Ludwig Institute For Cancer Research | Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
ATE391726T1 (de) | 1999-10-22 | 2008-04-15 | Sanofi Pasteur Ltd | Modifiziertes gp100 und dessen verwendung |
WO2002070003A1 (en) * | 2001-02-14 | 2002-09-12 | Genzyme Corporation | Altered peptide ligands |
AU2008206442B2 (en) | 2007-01-12 | 2012-10-18 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | gp100-specific T cell receptors and related materials and methods of use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2224113T5 (es) * | 1994-02-16 | 2009-05-01 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Polipeptido antigenico asociado al melanoma, epitopos del mismo y vacunas contra melanoma. |
JPH10505481A (ja) * | 1994-04-22 | 1998-06-02 | アメリカ合衆国 | メラノーマ抗原 |
ZA975858B (en) * | 1996-07-11 | 1998-09-01 | Akzo Nobel Nv | Melanoma associated peptide analogues and vaccines against melanoma |
-
1997
- 1997-07-01 ZA ZA975858A patent/ZA975858B/xx unknown
- 1997-07-08 AU AU36938/97A patent/AU3693897A/en not_active Abandoned
- 1997-07-08 AT AT97933664T patent/ATE206759T1/de active
- 1997-07-08 CA CA2259944A patent/CA2259944C/en not_active Expired - Lifetime
- 1997-07-08 EP EP97933664A patent/EP0934405B1/en not_active Expired - Lifetime
- 1997-07-08 DE DE69707296T patent/DE69707296T2/de not_active Expired - Lifetime
- 1997-07-08 WO PCT/EP1997/003712 patent/WO1998002538A1/en active IP Right Grant
- 1997-07-08 JP JP50560698A patent/JP4386463B2/ja not_active Expired - Lifetime
- 1997-07-08 ES ES97933664T patent/ES2165619T3/es not_active Expired - Lifetime
- 1997-07-10 ID IDP972391A patent/ID18726A/id unknown
-
2009
- 2009-05-12 JP JP2009115844A patent/JP5198354B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP4386463B2 (ja) | 2009-12-16 |
ID18726A (id) | 1998-05-07 |
ATE206759T1 (de) | 2001-10-15 |
WO1998002538A1 (en) | 1998-01-22 |
JP2000515739A (ja) | 2000-11-28 |
JP2009178166A (ja) | 2009-08-13 |
EP0934405B1 (en) | 2001-10-10 |
CA2259944C (en) | 2011-06-28 |
CA2259944A1 (en) | 1998-01-22 |
DE69707296D1 (de) | 2001-11-15 |
EP0934405A1 (en) | 1999-08-11 |
DE69707296T2 (de) | 2002-07-25 |
AU3693897A (en) | 1998-02-09 |
ES2165619T3 (es) | 2002-03-16 |
JP5198354B2 (ja) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1227295A (en) | Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma | |
HU9500571D0 (en) | Retro-, inverso-, and retro-inverso synthetic peptide analogues | |
WO2006014579A3 (en) | Enhancing class i antigen presentation with synthetic sequences | |
NZ232554A (en) | 100,000 dalton tumour cell glycoprotein antigen (l45), monoclonal antibodies thereto and medicaments | |
EP1630229A3 (en) | Melanoma antigens | |
WO1998033527A3 (en) | Cancer immunotherapy with semi-allogeneic cells | |
GB8703700D0 (en) | Monoclonal antibodies | |
HK1093314A1 (en) | Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens | |
ZA975858B (en) | Melanoma associated peptide analogues and vaccines against melanoma | |
ATE109512T1 (de) | Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind. | |
ATE344052T1 (de) | Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt. | |
AU2003241127A8 (en) | Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes | |
NZ213303A (en) | Plasmodium protein, dna sequence and vaccine | |
NZ515332A (en) | Lawsonia derived gene and related SodC polypeptides, peptides and proteins and their uses | |
WO1999024466A3 (en) | Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes | |
ES2017258A6 (es) | Un metodo para producir peptidos antigenicos relacionados con el antigeno p97 asociado a melanoma. | |
EP1502602A3 (en) | Methods for therapeutic vaccination | |
EP0320034A3 (en) | New immunologically active synthetic peptides useful for preparing an antimalarial vaccine | |
Kolesanova et al. | B-Cell Linear Epitopes in the Conservative Regions of Hepatitis C Virus Envelope Glycoproteins | |
Sarobe | Peptidos sinteticos en la induccion de la respuesta inmune humoral: Obtencion de anticuerpos neutralizantes frente al VIH-1. | |
Gulley et al. | Analysis of PSA-Specific T-Cell Responses of Prostate Cancer Patients Given a PSA-Based Vaccine on a Clinical Trial | |
RU92004487A (ru) | Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов | |
NO914094L (no) | Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer |